Bayer executive board member Werner Baumann will replace Brandicourt as division head, in addition to maintaining his responsibilities for group strategy, portfolio management and European markets.
(RReReporting by Ludwig Burger)
Market Closed -
Other stock markets
|
After market 03:59:51 pm | |||
27.4 EUR | +1.88% | 27.47 | +0.27% |
05:43pm | Bayer CEO wins first AGM shareholder vote | RE |
05:43pm | BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED A… | RE |
FRANKFURT (Reuters) - Germany's Bayer said the head of its healthcare division, Olivier Brandicourt, would quit to become chief executive officer of French peer Sanofi on April 2.
Bayer executive board member Werner Baumann will replace Brandicourt as division head, in addition to maintaining his responsibilities for group strategy, portfolio management and European markets.
(RReReporting by Ludwig Burger)
1st Jan change | Capi. | |
---|---|---|
-18.53% | 28.3B | |
+25.75% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+2.93% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.28% | 144B |